Cure My Disease

Don't miss your cure!

 Log in / Sign up

Jelly supplement aims to ease chemo side effects in cancer patients

NCT ID NCT07514754

Recruiting now Symptom relief Sponsor: Fondazione del Piemonte per l'Oncologia Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a jelly-based nutritional supplement in 52 people with head and neck, lung, or rectal cancer who are receiving standard cancer treatments like chemo or radiation. The supplement contains ingredients like arginine, omega-3, and olive oil, and is taken twice daily for up to 45 days. The goal is to see if it can reduce severe side effects and help patients stay on track with their treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Galenic Immunonutrition Formula (a jelly supplement with arginine, brewer's yeast, omega-3, olive oil, and other ingredients)
What this could lead to
If it works, this supplement could help reduce severe side effects from cancer treatments, making it easier for patients to complete their therapy.
What could go wrong
This is a small, early-phase study with no control group, so results may not be conclusive. The supplement may not reduce side effects or could cause digestive discomfort.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEAD AND NECK SQUAMOUS CELL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

head and neck squamous cell carcinoma lung cancer lung neoplasm rectal cancer Squamous Cell Carcinoma of Head and Neck

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEAD AND NECK SQUAMOUS CELL CARCINOMA LOCALLY ADVANCED RECTAL CANCER LUNG CANCER

Contacts and locations

Locations

  • Fondazione del Piemonte per l'Oncologia- IRCCS Istituto di Candiolo, Candiolo, Turin 10060

    RECRUITING

    Candiolo, Torino (TO), 10060, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.